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Abstract
Biliary excretion of certain bile acids is mediated by multidrug resistance associated protein 2 (Mrp2) and the bile salt
export pump (Bsep). In the present study, the transport properties of several bile acids were characterized in canalicular
membrane vesicles (CMVs) isolated from Sprague^Dawley (SD) rats and Eisai hyperbilirubinemic rats (EHBR) whose Mrp2
function is hereditarily defective and in membrane vesicles isolated from Sf9 cells infected with recombinant baculovirus
containing cDNAs encoding Mrp2 and Bsep. ATP-dependent uptake of [3H]taurochenodeoxycholate sulfate (TCDC-S)
(Km = 8.8 WM) and [3H]taurolithocholate sulfate (TLC-S) (Km = 1.5 WM) was observed in CMVs from SD rats, but not from
EHBR. In addition, ATP-dependent uptake of [3H]TLC-S (Km = 3.9 WM) and [3H]taurocholate (TC) (Km = 7.5 WM) was also
observed in Mrp2- and Bsep-expressing Sf9 membrane vesicles, respectively. TCDC-S and TLC-S inhibited the ATP-
dependent TC uptake into CMVs from SD rats with IC50 values of 4.6 WM and 1.2 WM, respectively. In contrast, the
corresponding values for Sf9 cells expressing Bsep were 59 and 62 WM, respectively, which were similar to those determined in
CMVs from EHBR (68 and 33 WM, respectively). By co-expressing Mrp2 with Bsep in Sf9 cells, IC50 values for membrane
vesicles from these cells shifted to values comparable with those in CMVs from SD rats (4.6 and 1.2 WM). Moreover, in
membrane vesicles where both Mrp2 and Bsep are co-expressed, preincubation with the sulfated bile acids potentiated their
inhibitory effect on Bsep-mediated TC transport. These results can be accounted for by assuming that the sulfated bile acids
trans-inhibit the Bsep-mediated transport of TC. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
As far as bile formation is concerned, continuous
vectorial secretion of bile salts from blood to bile via
hepatocytes is an important factor [1]. It has been
established that transporters located on the sinusoi-
dal (basal) and canalicular (apical) membrane are
involved in transcellular transport of bile acids
[2^4]. Uptake of bile salts into hepatocytes is medi-
ated by both Na-dependent and -independent trans-
porters. Recently, rat and human Na-taurocholate
co-transporting polypeptide (Ntcp) and organic
anion transporting polypeptides (oatp) have been
cloned [5,6].
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In addition, it has been shown that the biliary
excretion of organic anions is mediated by multidrug
resistance associated protein 2 (Mrp2) [7,8]. The sub-
strate speci¢city of Mrp2 has been investigated by
comparing transport across the bile canalicular mem-
brane in normal rats and Mrp2-de¢cient rats. These
mutant rats include Transport-De¢cient (TR3), Gro-
ningen Yellow (GY), and Eisai hyperbilirubinemic
rats (EHBR), which are a good model for studying
the pathogenesis of Dubin^Johnson syndrome in hu-
mans [7,8]. It has been shown that the substrates for
Mrp2 include glutathione- and glucuronide-conju-
gates and non-conjugated organic anions [7,8].
The transport of monovalent bile acids (such as
taurocholate; TC) across the bile canalicular mem-
brane, however, is mediated by another transporter
referred to as the bile salt export pump (Bsep). Using
membrane vesicles isolated from Sf9 cells infected
with recombinant baculovirus containing cDNA for
the sister of P-glycoprotein, which was cloned as a
homologue of MDR1 P-glycoprotein, it has been
shown that this protein exhibits Bsep activity [9]. It
was also demonstrated that the mutation in the Bsep
gene results in PFIC 2 in human subjects [10].
In contrast to the previously described monovalent
bile acids, it has been suggested that glucuronide- or
sulfate-conjugates of bile acids are transported via
Mrp2 and this hypothesis is based on the following
in vivo ¢ndings. Kuipers and his collaborators found
that the biliary excretion of cholate 3-O-glucuronide,
taurochenodeoxycholate-3-sulfate (TCDC-S) and
taurolithocholate-3-sulfate (TLC-S) was impaired in
GY rats [11,12]. This indicates that the transport of
these bile acid conjugates is mediated by Mrp2. This
conclusion was further con¢rmed by Takikawa et al.
[13] by in vivo experiments. In the present study, we
have performed in vitro experiments to characterize
the transport properties of sulfated bile acids
(TCDC-S and TLC-S) along with their interaction
with Bsep, since it has been demonstrated that the
sulfated bile acids a¡ect the disposition of TC in vivo
[14,15]. In our experiments, we used CMVs from SD
rats and EHBR and membrane vesicles from Sf9 cells
infected with the recombinant baculovirus containing
cDNAs for Mrp2 and Bsep.
2. Materials and methods
2.1. Materials
[3H]TC (2^5 Ci/mmol) was purchased from NEN
Life Science Products (Boston, MA). [3H]TLC-S and
[3H]TCDC-S were synthesized from lithocholate-3-
sulfate and chenodeoxycholate-3-sulfate, respectively,
using [2-3H]taurine (30.3 Ci/mmol) (NEN Life Sci-
ence Products) as described previously [16]. Cheno-
deoxycholate-3-sulfate was synthesized as described
previously [17]. Unlabeled TC, TLC, TCDC, TLC-
S, 17L-estradiol-17L-D-glucuronide (E217LG), ATP,
ADP, AMP, GTP, CTP, UTP, creatine phosphate
and creatine phosphokinase were purchased from
Sigma Chemical Co. (St. Louis, MO). All other
chemicals used were commercially available and of
reagent grade.
2.2. Preparation of CMVs
CMVs were prepared from male SD rats and
EHBR as described previously [18] and kept as a
suspension in 50 mM Tris bu¡er (pH 7.4) containing
250 mM sucrose. The membrane vesicles were then
frozen in liquid N2 and stored at 380‡C until use.
Protein concentrations were determined as reported
previously [18], using an assay kit (Bio Rad Labora-
tories, Richmond, CA) with bovine serum albumin
as a standard.
2.3. cDNA cloning of rat Bsep
Rat Bsep cDNA was cloned based on a sequence
described by Gerlo¡ et al. [9]. A cDNA probe was
prepared by a reverse transcription^polymerase chain
reaction (RT^PCR) on rat liver poly(A) RNA using
the forward (5P-dGAGCTGCTAGAAAGAAAAG-
G-3P) and reverse primers (5P-dACCAGAATGTAG-
TGCCATTC-3P). Reverse transcription was per-
formed using oligo(dT) primer at 30‡C for 10 min,
42‡C for 30 min and 99‡C for 5 min. Then, PCR was
carried out at 94‡C for 30 s, 37‡C for 30 s, and 72‡C
for 1 min for 40 cycles using Taq polymerase (Ta-
kara Shuzo Co. Kyoto, Japan). RT^PCR resulted in
the ampli¢cation of a partial sequence of rat Bsep
(246 bp: 1924^2270 bp) [9]. This fragment was used
as a probe to screen the full length cDNA from the
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cDNA library prepared from size-fractionated poly-
(A) RNA (4.0^6.0 kbp) using the ZAP ExpressTM
cDNA Synthesis and ZAP ExpressTM cDNA Giga-
pack III Gold Cloning kit (Stratagene, La Jolla,
CA).
2.4. Preparation of membrane vesicles from Sf9 cells
expressing rat Bsep and Mrp2
The Bac-to-Bac system (Life Technologies, Gai-
thersburg, MD) was used to establish the recombi-
nant baculovirus. Full length of Bsep and Mrp2 [19]
cDNAs were inserted into a donor plasmid (Life
Technologies) downstream of the polyhedrin pro-
moter. Sf9 cells were infected with the virus at
27‡C for 72 h. To establish co-expressed cells for
Bsep and Mrp2, Sf9 cells were infected with the 1-
to-1 mixed virus sup for these clones. To prepare
membrane vesicles, Sf9 cells were scraped from cul-
ture dishes, centrifuged at 1500Ug, and suspended in
hypotonic bu¡er consisting of 1 mM Tris^HCl (pH
7.0) and gently stirred for 1.5 h. Then, the solution
was centrifuged at 10 000Ug, and diluted with iso-
tonic bu¡er consisting of 10 mM Tris^HCl (pH 7.4)
and 250 mM sucrose. Disrupted cells were homoge-
nized with a glass/glass homogenizer, and mixed with
38% sucrose solution (Tris^Hepes, pH 7.4). After
centrifugation at 280 000Ug for 45 min, the turbid
layer was recovered and further centrifuged at
100 000Ug. The pellet was diluted with the transport
bu¡er (10 mM Tris, 250 mM sucrose and 10 mM
MgCl2c6H2O, pH 7.4), and passed through a 25-
gauge needle. These membrane vesicle preparations
were rapidly frozen in liquid N2 and kept at 380‡C
until use.
2.5. Uptake experiments
The uptake of [3H]TC, [3H]TCDC-S and [3H]TLC-
S was examined as reported previously [18]. The
transport medium contained the isotopically labeled
ligand, 5 mM ATP or 5 mM AMP, and an ATP-
regenerating system (10 mM creatine phosphate and
100 Wg/ml creatine phosphokinase). A 16-Wl aliquot
of transport medium was mixed rapidly with 4 Wl
vesicle suspension (10 Wg protein). In the inhibition
study, TCDC-S and TLC-S were dissolved in DMSO
and diluted to a ¢nal concentration (0.1% DMSO)
with transport bu¡er. In the control study, the same
concentration of DMSO was added to the transport
medium.
In the present study, we also examined the inhib-
itory e¡ect of sulfated bile acids on Bsep-mediated
transport of [3H]TC, by preloading the membrane
vesicles with TLC-S and TCDC-S. In the preloading
experiments, 10 Wg of membrane vesicles was incu-
bated in a 5-Wl aliquot of transport bu¡er containing
5 mM ATP or 5 mM AMP, ATP-generating system
and 1 WM TCDC-S or 1 WM TLC-S for 0 min, 1 min
and 3 min, and then a 45-Wl aliquot of transport
medium containing 1 WM [3H]TC, 5 mM ATP or
5 mM AMP, and an ATP-regenerating system was
added rapidly to examine the uptake of [3H]TC for
2 min.
The transport reaction was stopped by the addi-
tion of 1 ml ice-cold bu¡er containing 250 mM su-
crose, 0.1 M NaCl and 10 mM Tris^HCl (pH 7.4).
The stopped reaction mixture was ¢ltered through a
0.45-Wm HA ¢lter (Millipore Corp., Bedford, MA),
and then washed twice with 5 ml stop solution. The
radioactivity retained on the ¢lter and in the reaction
mixture was measured in a liquid scintillation coun-
ter (LS 6000SE, Beckman Instruments, Fullerton,
CA) following the addition of scintillation cocktail
(Clear-sol I, Nacalai Tesque, Tokyo, Japan). Ligand
uptake was normalized in terms of the amount of
membrane protein.
The ATP-dependent uptake was determined by
subtracting the uptake in the absence of ATP from
that in the presence of ATP. The kinetic parameters
were estimated as described previously [18].
2.6. Western blot analysis
Antiserum for rat Bsep was raised in rabbits
against an oligopeptide (the carboxyl terminal of
rat Bsep; AYYKLVITGAPIS) coupled with keyhole
limpet hemocyanin via m-maleimidobenzoyl-N-hy-
droxysuccinimide ester. Antiserum for rat Mrp2
(CP-2) was supplied by Dr J. Nakayama in Kuma-
moto University, Kumamoto, Japan, and this was
raised against the upstream region of carboxy-termi-
nal NBD (amino acid residues 1272^1285). For the
Western blotting, membrane proteins were solubi-
lized in a sample bu¡er consisting of 2% sodium
dodecyl sulfate (SDS), 30% glycerol and 0.01% bro-
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mophenol blue (pH 6.8). The suspension was sub-
jected to SDS^polyacrylamide gel electrophoresis
(PAGE), electrotransferred to a polyvinylidene di-
£uoride membrane (Millipore) and blotted as de-
scribed [20]. Blots were incubated with the antiserum
(diluted 1:1000) and visualized with [125I] anti-rabbit
antibody (Amersham Corp., Buckinghamshire, UK),
followed by exposure to Fuji imaging plates (Fuji
Photo Film Co., Kanagawa, Japan) for 3 h at
room temperature, and analyzed with an imaging
analyzer (BSA 2000, Fuji Photo Film Co.).
3. Results
3.1. Uptake of [3H]TCDC-S and [3H]TLC-S by
CMVs
The time pro¢le for the uptake of [3H]TCDC-S (1
WM) and [3H]TLC-S (1 WM) by CMVs from SD rats
and EHBR was examined (Fig. 1). In CMVs from
SD rats, but not from EHBR, uptake of [3H]TCDC-
S and [3H]TLC-S was stimulated by the presence of
ATP, and increased linearly up to 2 min. Kinetic
analysis revealed that the ATP-dependent uptake of
[3H]TCDC-S and [3H]TLC-S into CMVs from SD
rats could be described by one saturable component
with Km = 8.8 þ 1.3 WM and Vmax = 659 þ 58 pmol/
min per mg protein, and Km = 1.5 þ 0.3 WM and
Vmax = 112 þ 15 pmol/min per mg protein, respec-
tively (Fig. 2).
3.2. Uptake of [3H]TC and [3H]TLC-S by
membrane vesicles from Sf9 cells expressing Bsep
and Mrp2
cDNA product for Bsep and Mrp2 was expressed
in Sf9 cells with the baculovirus expression system.
In order to con¢rm the expression of these transport-
ers, Western blotting was performed in CMVs from
SD rats and membrane vesicles from Sf9 cells ex-
pressing Bsep and Mrp2 (Fig. 3). In the case of
anti-serum against rat Bsep, approximately 170 and
160 kDa proteins were detected in CMVs and in
membrane vesicles from Bsep-expressing Sf9 cells,
respectively (Fig. 3b). In the same manner, approx-
Fig. 1. Time-dependent uptake of [3H]TCDC-S and [3H]TLC-S by CMVs. CMVs prepared from SD rats (a,b) and EHBR (c,d) were
incubated at 37‡C with (b) or without (a) ATP and ATP-regenerating system in the medium. The concentration of [3H]TCDC-S (a,c)
and [3H]TLC-S (b,d) was 1 WM. Each point and vertical bar represent the mean þ S.E. of three di¡erent experiments.
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imately 190 and 180 kDa proteins were detected by
antiserum for Mrp2 in CMVs and membrane vesicles
from Mrp2-expressing Sf9 cells, respectively (Fig.
3a).
The time pro¢le for the uptake of [3H]TC by mem-
brane vesicles prepared from rat Bsep-expressing Sf9
cells is shown in Fig. 4a. The Bsep-mediated uptake
of [3H]TC (1 WM) was stimulated by the presence of
ATP and the uptake was linear up to 2 min. In con-
trast, no ATP-dependent uptake of [3H]TLC-S was
observed in Bsep-expressing membrane vesicles (data
not shown). Kinetic analysis of the concentration-de-
pendent uptake of [3H]TC gave a Km of 7.5 þ 1.7 WM
and a Vmax of 295 þ 38 pmol/min per mg protein
(Fig. 4c).
ATP-dependent uptake of [3H]TLC-S by Mrp2
was also con¢rmed by membrane vesicles from
Mrp2-expressing Sf9 cells. [3H]TLC-S was taken up
linearly by these membrane vesicles in an ATP-de-
pendent manner up to 2 min (Fig. 4b). Kinetic anal-
ysis revealed that the Km and Vmax values for the
ATP-dependent uptake of [3H]TLC-S via Mrp2
were 3.9 þ 0.4 WM and 1486 þ 101 pmol/min per mg
protein (Fig. 4d). In contrast, no ATP-dependent
uptake of [3H]TC was observed in Mrp2 expressing
membrane vesicles (data not shown).
To determine the nucleotide dependence, transport
of [3H]TLC-S was measured in the presence of sev-
eral kinds of nucleotide phosphates. As shown in
Fig. 5a, replacement of ATP by ADP or AMP re-
duced the uptake of [3H]TLC-S, suggesting that ATP
hydrolysis is necessary for uptake of [3H]TLC-S. Of
Fig. 3. Western blotting for CMVs and membrane vesicles prepared from Mrp2 and Bsep-expressing Sf9 cells. (a) Plasma membrane
vesicles (30 Wg) were size fractionated by 10% SDS^electrophoresis and electrophoretically transferred to a polyvinylidene di£uoride
membrane for immunoblotting with antiserum against MRP2. (b) Plasma membrane vesicles (100 Wg) were applied for immunoblot-
ting with antiserum against Bsep.
Fig. 2. Eadie^Hofstee plot for the uptake of [3H]TCDC-S and [3H]TLC-S by CMVs prepared from SD rats. CMVs prepared from
SD rats were incubated at 37‡C for 2 min, with or without ATP and ATP-regenerating system in the medium containing di¡erent
concentration of TCDC-S (a) and TLC-S (b). The ATP-dependent uptake was obtained by subtracting the value in the absence of
ATP from that in its presence. Each point and bar represent the mean þ S.E. of three di¡erent experiments.
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the four nucleotide triphosphates tested, ATP was
the most potent in stimulating the uptake of
[3H]TLC-S (Fig. 5a). Moreover, in order to con¢rm
that the isotope count associated with the vesicles
re£ects transport into membrane vesicles, rather
than binding to the membrane surface, the uptake
of [3H]TLC-S was measured in the presence of sev-
eral di¡erent concentrations of sucrose in the trans-
port medium (Fig. 5b). The uptake was osmotically
sensitive, suggesting that the major part of the ATP-
dependent uptake of [3H]TLC-S is due to uptake,
and not to adsorption to the membrane vesicle sur-
face.
3.3. Trans-inhibitory e¡ect of TCDC-S, TLC-S and
E217LG on the ATP-dependent uptake of
[3H]TC
The bile acid transport systems on the bile canal-
icular membrane was further characterized by exam-
ining the e¡ect of E217LG, TCDC-S and TLC-S on
the ATP-dependent uptake of [3H]TC by CMVs
from SD rats and EHBR, and that by membrane
vesicles isolated from rat Bsep-expressing Sf9 cells
(Fig. 6). The uptake of [3H]TC was inhibited by
TCDC-S in a concentration-dependent manner with
an IC50 of 4.6 þ 1.0 WM, 67.9 þ 16.7 WM and
58.7 þ 9.6 WM for CMVs from SD rats, EHBR and
rat Bsep-expressing Sf9 vesicles, respectively (Fig.
6a). In the same manner, the IC50 values of TLC-S
for [3H]TC uptake were determined as 1.2 þ 0.3 WM,
33.0 þ 6.3 WM and 61.9 þ 19.6 WM for CMVs from
SD rats, EHBR and rat Bsep-expressing Sf9 vesicles,
respectively (Fig. 6b). By focusing on the fact that
the sulfated bile acids give the lower IC50 values on
Bsep-mediated transport of TC when Mrp2 is co-ex-
pressed, we prepared membrane vesicles from Sf9
cells co-expressing Bsep and Mrp2. Co-expression
of Mrp2 and Bsep in membrane vesicles resulted in
the shift of the IC50 values in a similar fashion to
Fig. 4. Uptake of [3H]TC and [3H]TLC-S by membrane vesicles from Sf9 cells expressing Bsep and MRP2. Membrane vesicles iso-
lated from Bsep (a) or Mrp2 (b) expressing Sf9 cells were incubated at 37‡C for the indicated period, with (b) or without (a) ATP
and ATP-regenerating system in the medium containing 1 WM [3H]TC and [3H]TLC-S, respectively. For comparison, the uptake into
the control membrane vesicles in the presence (F) and absence (E) is indicated in panels a and b. The ATP-dependent uptake of li-
gands was obtained by subtracting the value in the absence of ATP from that in its presence. The saturable Bsep-mediated TC trans-
port (c) and Mrp2-mediated TLC-S transport (d) are shown as Eadie^Hofstee plots. Each point and bar represent the mean þ S.E. of
three di¡erent experiments.
BBAMEM 78015 1-3-01
H. Akita et al. / Biochimica et Biophysica Acta 1511 (2001) 7^1612
that of CMVs from SD rats (4.6 and 1.2 WM) (Fig.
6a,b).
Moreover, as control experiments inhibitory e¡ect
of 100 WM E217LG on the ATP-dependent uptake of
[3H]TC into the membrane vesicles was also charac-
terized [21]. E217LG inhibits the uptake of [3H]TC
only in CMVs isolated from SD rats and in mem-
brane vesicle isolated from Bsep/Mrp2 co-expressing
Sf9 cells (16% and 36% of the control, respectively),
but not signi¢cantly in CMVs from EHBR or mem-
brane vesicles from Bsep-expressing Sf9 cells (Fig. 6c
as reported previously). These results are consistent
with the hypothesis that the sulfated bile acids are
concentrated in the membrane vesicles due to the
presence of Mrp2, and then trans-inhibit the Bsep-
mediated transport of [3H]TC (as proposed previ-
ously for E217LG [21]).
To con¢rm the trans-inhibitory e¡ect of TCDC-S
and TLC-S, sulfated bile acids were preloaded to
membrane vesicles with the sulfated bile acids for
0, 1 and 3 min, and then the ATP-dependent uptake
of [3H]TC was measured for 2 min. The ATP-depen-
dent transport of [3H]TC into the membrane vesicle
isolated from Mrp2/Bsep co-expressing Sf9 was in-
hibited by TCDC-S in a preincubation time-depen-
dent manner (60^75% of control), whereas no signif-
icant inhibitory e¡ect was observed in Bsep-
expressing membrane vesicles (Fig. 7). Similarly,
ATP-dependent transport of [3H]TC into the Mrp2/
Bsep co-expressing membrane vesicles was inhibited
by the preincubation of TLC-S (70^80% of control),
whereas no signi¢cant inhibitory e¡ect was observed
in Bsep-expressing membrane vesicles (Fig. 7).
4. Discussion
Previous in vivo ¢ndings suggested that sulfate-
conjugated bile acids are secreted into the bile via
Mrp2 [11,12]. In the present study, we have charac-
Fig. 6. Inhibitory e¡ect of TCDC-S and TLC-S on ATP-dependent uptake of [3H]TC. CMVs prepared from SD rats (b) and EHBR
(a), and membrane vesicles from Bsep (F) and Bsep/Mrp2 co-expressing (E) Sf9 were incubated at 37‡C for 2 min, with or without
ATP and ATP-regenerating system in the medium containing [3H]TC (1 WM) and various concentration of TCDC-S (a), TLC-S (b)
and 100 WM E217LG. The ATP-dependent uptake was obtained by subtracting the value in the absence of ATP from that in its pres-
ence. Each point and vertical bar represent the mean þ S.E. of three di¡erent experiments.
Fig. 5. Nucleotide speci¢city and osmotic sensitivity of
[3H]TLC-S transport by membrane vesicles from MRP2-ex-
pressing Sf9 cells. (a) [3H]TLC-S uptake to membrane vesicles
(5 Wg) from MRP2-expressing Sf9 cells was measured in the
presence of indicated nucleotides (5 WM) for 1 min at 37‡C. No
regenerating system was included in these experiments. (b)
Membrane vesicles (5 Wg) from MRP2 expressing Sf9 cells were
preincubated at 37‡C for 3 min in the medium containing dif-
ferent concentrations of sucrose (0.25, 0.46, 0.88, 2 and 10
mM). [3H]TLC-S uptake was measured in the presence (closed)
and absence (opened) of 5 mM ATP. Vertical bars represent
the mean þ S.E. of three di¡erent experiments.
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terized the transport of radiolabeled TCDC-S and
TLC-S in CMVs from SD rats and EHBR and mem-
brane vesicles expressing Bsep and Mrp2. Expression
of Mrp2 and Bsep in the membrane vesicles isolated
from Sf9 cells was con¢rmed by Western blot. The
molecular mass of these transporters in Sf9 cells was
smaller than that in CMVs, presumably due to the
incomplete glycosylation in Sf9 cells. As shown in
Fig. 1, ATP stimulated the uptake of both TCDC-
S and TLC-S into CMVs from SD rats, but not from
EHBR, indicating that these sulfated bile acids are
substrates for Mrp2. This hypothesis was directly
demonstrated by the uptake study of [3H]TLC-S
into membrane vesicles isolated from Mrp2-
expressed Sf9 cells (Fig. 4b,d). These results are con-
sistent with the recent report by Stieger et al. [21],
performed independently. The uptake was supported
to the greatest extent by ATP among the nucleotide
triphosphates examined, followed by GTPsUTP =
CTP (Fig. 5a), which is characteristic of transport by
MRP family proteins [21]. Since the ATP-dependent
uptake of [3H]TLC-S was osmotically sensitive (Fig.
5b), this uptake represents transport into the intra-
vesicular space, rather than binding to the vesicle
surface. Moreover, the Km values for the uptake of
TLC-S were in the same range for CMVs and
Mrp2-expressing Sf9 membrane vesicles (1.5 WM vs.
3.9 WM) (Figs. 2 and 4). These results are reasonable
if we consider that there is a degree of overlap in the
substrates of MRP1 and Mrp2. In fact, glucuronide
conjugates of bile acids, along with TLC-S, are also
substrates for MRP1 [22].
In contrast to the sulfated bile acids, the monova-
lent bile acids are excreted into the bile via Bsep as
demonstrated by Gerlo¡ et al. [9] and Stieger et al.
[21]. These results were also reproduced in the
present study. As shown in Fig. 4a, TC was taken
up by membrane vesicles from Bsep-expressing Sf9
cells in an ATP-dependent manner. This ATP-depen-
dent uptake was saturable with a Km of 7.5 WM (Fig.
4c), which was comparable with that determined in
CMVs (2.1 WM; Stieger et al. [23] and 6.0 WM; Sato
et al., unpublished observation), and in membrane
vesicles from Bsep-expressing Sf9 cells (5.3 WM;
Gerlo¡ et al. [9]). The fact that no ATP-dependent
uptake of [3H]TLC-S was observed in Bsep-express-
ing membrane vesicles (data not shown) is consistent
with the suggestion that this sulfate conjugated bile
acid is transported across the bile canalicular mem-
brane predominantly via Mrp2.
In order to characterize the transport nature of
bile acids more precisely, we also examined the in-
hibitory e¡ect of TCDC-S and TLC-S on the ATP-
dependent uptake of TC by CMVs and by membrane
vesicles from Sf9 cells expressing cloned transporter
cDNA products. Although TCDC-S and TLC-S in-
hibited [3H]TC uptake into these membrane prepa-
rations, the IC50 values in CMVs from SD rats were
much lower than those in membrane vesicles from
Bsep-expressing Sf9 membrane vesicles (Fig. 6a,b).
Then, we examined the inhibitory e¡ect of sulfated
bile acids on the transport of TC in CMVs from
EHBR and found that the IC50 values are compara-
ble with those determined in Bsep-expressing Sf9
Fig. 7. Preincubation time-dependent inhibitory e¡ect of
TCDC-S and TLC-S on ATP-dependent uptake of [3H]TC.
Membrane vesicles isolated from Bsep/Mrp2 and Bsep express-
ing Sf9 cells (10 Wg) were incubated in a 5-Wl aliquot of trans-
port bu¡er containing 5 mM ATP or 5 mM AMP, ATP-gener-
ating system and 1 WM TCDC-S or 1 WM TLC-S for 0 min
(closed bar), 1 min (stippled bar) and 3 min (open bar), and
then a 45-Wl aliquot of transport medium containing 1 WM
[3H]TC, 5 mM ATP or 5 mM AMP, and an ATP-regenerating
system was added to examine the uptake of [3H]TC for 2 min.
The ATP-dependent uptake was obtained by subtracting the
value in the absence of ATP from that in its presence. ATP-De-
pendent uptake of [3H]TC without preincubation (0 min) was
de¢ned as 100%. Each point and vertical bar represents the
mean þ S.E. of three di¡erent experiments. Signi¢cantly di¡erent
from control by Student t-test (**; P6 0.01, *; P6 0.05).
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membrane vesicles (Fig. 6a,b). These results indicate
that the IC50 values of sulfated bile acids for Bsep-
mediated transport of TC depend on the presence of
Mrp2; the IC50 values in membrane vesicles express-
ing both Bsep and Mrp2 (CMVs from SD rats) are
signi¢cantly lower than those in membrane vesicles
expressing only Bsep (CMVs from EHBR and Bsep-
expressing Sf9 cells) (Fig. 6a,b). In order to con¢rm
these ¢ndings, we also determined the IC50 values in
membrane vesicles expressing both Bsep and Mrp2,
and found that the values are comparable with those
determined in CMVs from SD rats (Fig. 6a,b). These
¢ndings are consistent with those reported by Stieger
et al. [21] who found that the inhibition of the uptake
of TC by E217LG was much greater in CMVs from
Wistar rats and Bsep/Mrp2 co-expressing Sf9 mem-
brane vesicles, compared with that in CMVs from
TR3 and Bsep-expressing Sf9 cells. We were also
able to con¢rm that 100 WM E217LG inhibits the
ATP-dependent uptake of [3H]TC only in CMVs
from SD rats and Bsep/Mrp2 co-expressing Sf9
membrane vesicles (Fig. 6c). Stieger et al. [21] pro-
posed a possible hypothesis to account for these re-
sults, namely, that Mrp2 substrates (such as E217LG)
trans-inhibit the function of Bsep [21]. In the present
study, in Sf9 membrane vesicles expressing both Bsep
and Mrp2, TCDC-S and TLC-S are e⁄ciently taken
up into the membrane vesicles (Figs. 1 and 4), and
may inhibit the function of Bsep from inside the
vesicles (trans-inhibition). In contrast, since CMVs
from EHBR and membrane vesicles from Bsep-ex-
pressing Sf9 cells do not express Mrp2, these sulfated
bile acids can inhibit Bsep-mediated uptake only
from outside the vesicles (cis-inhibition). Alterna-
tively, sulfated bile acids could be concentrated
enough to trans-inhibit the function of Bsep by low
a⁄nity transporter(s) expressed on the canalicular
membrane of EHBR and plasma membrane of Sf9
cells at their higher concentrations.
We also found that the preincubation of the sul-
fated bile acids reduce the uptake of [3H]TC uptake
into Mrp2 and Bsep co-expressing membrane
vesicles, but not into Bsep expressing membrane
vesicles, in a time-dependent manner (Fig. 7). Stieger
et al. also showed a time-dependent inhibitory e¡ect
of E217LG on TC uptake by Bsep/Mrp2 co-express-
ing Sf9 membrane vesicles [21]. The e¡ect of E217LG
was signi¢cant after a longer incubation time when a
signi¢cant amount of E217LG is present in the intra-
vesicular space [21]. Although we cannot exclude the
possibility that the transport characteristics of Bsep
are modulated by Mrp2 via a protein^protein inter-
action, the results of the present study and those by
Stieger et al. [21] are consistent with the presence of
trans-inhibition of Bsep by Mrp2 substrates. Based
on the hypothesis that sulfated bile acid inhibit the
function of Bsep from the extracellular domain, al-
losteric interaction rather than the simple competi-
tive inhibition at TC binding site located in the intra-
cellular domain, may be the most plausible
explanation to account for the trans-inhibition mech-
anism.
However, the physiological signi¢cance for the
trans-inhibitory e¡ect of sulfated bile acids on the
function of Bsep still remains to be clari¢ed. As far
as the e¡ect of sulfated bile acids was concerned,
Yousef et al. [14,15] indicated that infusion of sul-
fated bile acids including TCDC-S reduced the bili-
ary excretion of phospholipids and cholesterol, along
with the secretion of endogenous bile acids, whereas
the same treatment signi¢cantly increased the bile
salt-independent bile £ow rate. In further studies,
we plan to compare the in vivo e¡ect of sulfated
bile acids on the biliary excretion of TC in both
normal SD rats and EHBR. Recently, Huang et al.
[24] indicated that, after i.v. administration of the
cholestatic dose of E217LG, cholestasis was induced
in normal Wistar rats, but not in Mrp2-de¢cient
TR3 rats. However, the concentration of this steroid
in the bile was similar between normal and TR3 rats
[24]. These results are consistent with the hypothesis
that, at least for E217LG, the trans-inhibition mech-
anism may not be involved in the pathogenesis of
cholestasis.
In conclusion, we have demonstrated that TCDC-
S and TLC-S are transported by Mrp2. In addition,
TCDC-S and TLC-S inhibit the function of Bsep
with lower IC50 values in membrane vesicles from
SD rats and Sf9 cells expressing both Bsep and
Mrp2 compared with those in membrane vesicles
from EHBR and Bsep-expressing Sf9. These data
can be accounted for by assuming the presence of a
trans-inhibition mechanism for Bsep function by sul-
fated bile acids.
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